Literature DB >> 21411053

Surgical outcomes in gynecologic oncology in the era of robotics: analysis of first 1000 cases.

Pamela J Paley1, Dan S Veljovich, Chirag A Shah, Elise N Everett, Amy E Bondurant, Charles W Drescher, William A Peters.   

Abstract

OBJECTIVE: We sought to examine outcomes in an expanding robotic surgery (RS) program. STUDY
DESIGN: In all, 1000 women underwent RS from May 2006 through December 2009. We analyzed patient characteristics and outcomes. A total of 377 women undergoing RS for endometrial cancer staging (ECS) were compared with the historical data of 131 undergoing open ECS.
RESULTS: For the entire RS cohort of 1000, the conversion rate was 2.9%. Body mass index increased over 3 time intervals: T1 = 26.2, T2 = 29.5, T3 = 30.1 (T1:T2, P = .01; T1:T3, P = .0001; T2:T3, P = .037). Increasing body mass index was not associated with increased major complications: T1 = 8.7%, T2 = 4.3%, T3 = 5.7%. In the ECS cohort, as compared with open ECS, women undergoing RS had lower blood loss (46.9 vs 197.6 mL, P < .0001), shorter hospitalization (1.4 vs 5.3 days, P < .0001), fewer major complications (6.4% vs 20.6%, P < .0001), with higher lymph node counts (15.5 vs 13.1, P = .007).
CONCLUSION: RS is associated with favorable morbidity and conversion rates in an unselected cohort. Compared to laparotomy, robotic ECS results in improved outcomes.
Copyright © 2011 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21411053     DOI: 10.1016/j.ajog.2011.01.059

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  19 in total

1.  Robotic surgery compared with laparotomy for high-grade endometrial cancer.

Authors:  Alok Pant; Julian Schink; John Lurain
Journal:  J Robot Surg       Date:  2014-01-12

2.  Comparative outcomes between robotic and abdominal radical hysterectomy for IB1 cervical cancer: Results from a single high volume institution.

Authors:  David W Doo; C Tyler Kirkland; Lauren H Griswold; Gerald McGwin; Warner K Huh; Charles A Leath; Kenneth H Kim
Journal:  Gynecol Oncol       Date:  2019-03-06       Impact factor: 5.482

3.  Health care cost consequences of using robot technology for hysterectomy: a register-based study of consecutive patients during 2006-2013.

Authors:  Karin Rosenkilde Laursen; Vibe Bolvig Hyldgård; Pernille Tine Jensen; Rikke Søgaard
Journal:  J Robot Surg       Date:  2017-07-10

4.  Imaging across the life span: innovations in imaging and therapy for gynecologic cancer.

Authors:  Meng Xu-Welliver; William T C Yuh; Julia R Fielding; Katarzyna J Macura; Zhibin Huang; Ahmet S Ayan; Floor J Backes; Guang Jia; Mariam Moshiri; Jun Zhang; Nina A Mayr
Journal:  Radiographics       Date:  2014 Jul-Aug       Impact factor: 5.333

Review 5.  Robot-assisted hysterectomy for endometrial and cervical cancers: a systematic review.

Authors:  Immaculate F Nevis; Bahareh Vali; Caroline Higgins; Irfan Dhalla; David Urbach; Marcus Q Bernardini
Journal:  J Robot Surg       Date:  2016-07-16

6.  The effect of increased experience on complications in robotic hysterectomy for malignant and benign gynecological disease.

Authors:  Celine Lönnerfors; Petur Reynisson; Barbara Geppert; Jan Persson
Journal:  J Robot Surg       Date:  2015-10-13

7.  Controversies in the treatment of early stage endometrial carcinoma.

Authors:  Joshua Z Press; Walter H Gotlieb
Journal:  Obstet Gynecol Int       Date:  2012-03-26

8.  The impact of robotic surgery on gynecologic oncology.

Authors:  Alpa M Nick; Pedro T Ramirez
Journal:  J Gynecol Oncol       Date:  2011-09-28       Impact factor: 4.401

9.  Definition of compartment based radical surgery in uterine cancer-part I: therapeutic pelvic and periaortic lymphadenectomy by Michael höckel translated to robotic surgery.

Authors:  Rainer Kimmig; Antonella Iannaccone; Paul Buderath; Bahriye Aktas; Pauline Wimberger; Martin Heubner
Journal:  ISRN Obstet Gynecol       Date:  2013-03-25

10.  Robotic surgical skills: acquisition, maintenance, and degradation.

Authors:  Eric L Jenison; Karen M Gil; Thomas S Lendvay; Michael S Guy
Journal:  JSLS       Date:  2012 Apr-Jun       Impact factor: 2.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.